#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell type acute leukaemia Metabolic disorder Philadelphia positive chronic myeloid leukaemia Huntington's disease Fallopian tube cancer Pleural mesothelioma malignant Chronic graft versus host disease in intestine Fms-like tyrosine kinase 3 positive Vascular malformation Hypereosinophilic syndrome Neuroendocrine tumour of the lung Neurotrophic keratopathy Albright's disease Hairy cell leukaemia Cryoglobulinaemia More trials…

    Learn about Rare Diseases

    Retinoblastoma – Treatment Systemic mastocytosis – Diagnostics Retinoblastoma – Life with Disease Pleural mesothelioma malignant – Treatment Nephrotic syndrome – Diagnostics Prader-Willi syndrome – Diagnostics Breast angiosarcoma metastatic – Trials in Disease Soft tissue sarcoma – Basic Information Familial amyotrophic lateral sclerosis – Diagnostics Prader-Willi syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oxaliplatin Tremelimumab Imifoplatin GRNA-001 Ferric Derisomaltose Metyrapone Bp PIROXICAM Radiprodil Riociguat RNMB1 Rocuronium Bromide ATOVAQUONE Blinatumomab Atidarsagene Autotemcel Clenbuterol Hydrochloride Etuvetidigene Autotemcel Dexamethasone Ph. Eur. Leuprorelin Etamsylate Ublituximab More therapies…

    Learn about Your Condition

    Cystic fibrosis lung Stress Nasopharyngeal cancer Type IIa hyperlipidaemia Complicated appendicitis Tonsillitis Dry eye Corneal graft failure Gastric cancer stage IV Lysosomal storage disorder Abdominal infection Cushing's syndrome Retinitis pigmentosa Critical illness Senile dementia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina…

Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina W Rzeszowie

Ul. Fryderyka Szopena 2, Rzeszow, 35-055, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • A Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    2 1
    Germany Greece Poland Spain

  • A Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Czechia Germany Poland

  • A Study Testing Zasocitinib Compared to Placebo in Adults with Nonsegmental Vitiligo to See How Well It Works and How Safe It Is

    Not recruiting

    2 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Zasocitinib
    France Italy Poland Spain

  • Study of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years

    Not recruiting

    3 1
    Czechia France Italy Poland Spain

  • Comparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Deucravacitinib
    • Zasocitinib
    Bulgaria Czechia France Latvia Poland

  • Study of ruxolitinib cream applied to the skin for people with hidradenitis suppurativa

    Not recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Ruxolitinib
    Belgium Bulgaria France Germany The Netherlands Poland +1

  • Study on IMVT-1402 for Patients with Active Cutaneous Lupus Erythematosus

    Not recruiting

    2 1
    Investigated Diseases:
    • Cutaneous lupus erythematosus
    Investigated Drugs:
    • IMEROPRUBART
    Bulgaria Germany Greece Poland Spain

  • Study on the Effectiveness and Safety of Tildrakizumab for Patients with Moderate to Severe Genital Psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Tildrakizumab
    Bulgaria Hungary Poland

  • Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1
    Investigated Drugs:
    • Envudeucitinib
    Austria Belgium Bulgaria Czechia Estonia France +7

  • Study on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Drugs:
    • Ro7790121
    France Germany Italy Poland Spain
Previous Page
1 2 3 4 5 6 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!